Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer.

Potter, Adam S; Patel, Ashley; Khawaja, Muzamil; Chen, Christopher; Zheng, Henry; Kaczmarek, Jessica; Gao, Feng; Karimzad, Kaveh; Song, Juhee; Koutroumpakis, Efstratios; Khalaf, Shaden; Iliescu, Cezar; Deswal, Anita; Palaskas, Nicolas L

Potter, Adam S; Patel, Ashley; Khawaja, Muzamil; Chen, Christopher; Zheng, Henry; Kaczmarek, Jessica; Gao, Feng; Karimzad, Kaveh; Song, Juhee; Koutroumpakis, Efstratios; Khalaf, Shaden; Iliescu, Cezar; Deswal, Anita; Palaskas, Nicolas L.

Afiliación

Potter AS; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Patel A; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Khawaja M; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Chen C; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Zheng H; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Kaczmarek J; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Gao F; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Karimzad K; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Song J; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Koutroumpakis E; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Khalaf S; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Iliescu C; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Deswal A; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Palaskas NL; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

JACC CardioOncol ; 4(3): 341-350, 2022 Sep.

Article en En | MEDLINE | ID: mdl-36213361

Palabras clave

CVA, cerebrovascular accident; DOAC; DOAC, direct oral anticoagulant agent; GIB, gastrointestinal bleeding; ICH, intracranial hemorrhage; LMWH, lowmolecular weight heparin; NVAF, nonvalvular atrial fibrillation; TIA, transient ischemic attack; VKA, vitamin K antagonist; VTE, venous thromboembolism; bleeding; cancer; nonvalvular atrial fibrillation; stroke; vitamin K antagonist; warfarin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JACC CardioOncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google